Business
Why the Mesoblast (ASX:MSB) share price is charging higher today – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is pushing higher on Monday after providing an update on its remestemcel-L for the treatment of SR-aGVHD…
The Mesoblast limited(ASX: MSB) share price has started the week strongly and is charging higher.
In early trade the allogeneic cellular medicines company’s shares are up 3% to $4.45.
Why is the Mesoblast share price pushing higher?
Investors have been buying the company’s shares this morning after its revealed results from a study of its remestemcel-L product in children with steroid-refractory acute graft versus host disease (SR-aGVHD).
According to the release, the results provide in vivo biomarker…
-
Noosa News9 hours agoChef Sophie Phipps prepares to open restaurant at 30-acre Alsahwa Estate
-
Business7 hours agoIs this the best ASX 200 share to buy for growth?
-
General16 hours agoThe Israel-Iran war: the moral failure of a policy of neutrality
-
General14 hours agoHow the US struck Iran’s nuclear facilities in Operation Midnight Hammer